3.66BMarket Cap-13.04P/E (TTM)
35.035High33.330Low736.49KVolume35.000Open35.400Pre Close25.03MTurnover0.74%Turnover RatioLossP/E (Static)108.08MShares39.61052wk High4.36P/B3.39BFloat Cap13.48052wk Low--Dividend TTM100.04MShs Float193.540Historical High--Div YieldTTM4.82%Amplitude13.480Historical Low33.983Avg Price1Lot Size
Zai Lab Stock Forum
China Accepts TIVDAK Application: 45% Lower Death Risk in Cervical Cancer Trial
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet